Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.12.663011662720.2313
Domestic EquitiesMax Healthcare Institute Ltd.6.38879305010.2071
Domestic EquitiesCipla Ltd.5.7413636029.1727
Domestic EquitiesDr. Reddy's Laboratories Ltd.5.1354717078.2047
Domestic EquitiesDivi's Laboratories Ltd.5.1238141748.1861
Domestic EquitiesApollo Hospitals Enterprise Ltd.5.0070120917.9996
Domestic EquitiesLupin Ltd.3.5845282405.7269
Domestic EquitiesTorrent Pharmaceuticals Ltd.2.8548141304.5611
Domestic EquitiesFortis Healthcare Ltd.2.4586562483.9281
Domestic EquitiesAurobindo Pharma Ltd.2.3252320113.7149
Domestic EquitiesMankind Pharma Ltd.2.1422141153.4225
Domestic EquitiesZydus Lifesciences Ltd.1.7062307532.7259
Domestic EquitiesLaurus Labs Ltd.1.6001416762.5564
Domestic EquitiesGlenmark Pharmaceuticals Ltd.1.5757163362.5175
Domestic EquitiesAlkem Laboratories Ltd.1.535450252.4531
Domestic EquitiesIPCA Laboratories Ltd.1.5284162592.4419
Domestic EquitiesBiocon Ltd.1.0657498281.7026
Domestic EquitiesPiramal Pharma Ltd.0.9905704101.5825
Domestic EquitiesSyngene International Ltd.0.9714213711.5520
Domestic EquitiesSuven Pharmaceuticals Ltd.0.9156127101.4629
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Ltd.0.914850741.4615
Domestic EquitiesAjanta Pharma Ltd.0.890754251.4230
Domestic EquitiesNarayana Hrudayalaya ltd.0.879983081.4058
Domestic EquitiesGland Pharma Ltd.0.874087691.3964
Domestic EquitiesGlobal Health Ltd.0.722396301.1540
Total 69.5953 111.1905
Cash & Cash Equivalents and Net AssetsNet Receivables/(Payables)0.3452 0.5515
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd.0.0563 0.0899
Cash & Cash Equivalents and Net AssetsAccrued Interest0.0000 0.0001
Total 0.4015 0.6415
Overseas EquitiesELI LILLY & CO5.525712498.8282
Overseas EquitiesJOHNSON & JOHNSON3.151035475.0342
Overseas EquitiesABBVIE INC3.010126824.8091
Overseas EquitiesNovo Nordisk A/S1.891450853.0219
Overseas EquitiesMERCK & CO.INC1.884339193.0105
Overseas EquitiesABBOTT LABORATORIES1.758624752.8097
Overseas EquitiesNOVARTIS AG1.727628932.7601
Overseas EquitiesTHERMO FISHER SCIENTIFIC INC1.52205712.4316
Overseas EquitiesINTUITIVE SURGICAL INC1.39555262.2295
Overseas EquitiesAMGEN INC1.35518122.1650
Overseas EquitiesDANAHER CORP1.06309681.6983
Overseas EquitiesGILEAD SCIENCES INC1.057017611.6887
Overseas EquitiesSTRYKER CORP1.02295131.6343
Overseas EquitiesVERTEX PHARMACEUTICALS INC0.99983851.5974
Overseas EquitiesMEDTRONIC PLC0.919819111.4696
Overseas EquitiesRegeneron Pharmaceuticals Inc0.55721640.8902
Overseas EquitiesBECTON DICKINSON AND CO0.52644290.8410
Overseas EquitiesAGILENT TECHNOLOGIES INC0.26954300.4305
Overseas EquitiesIQVIA HOLDINGS INC0.26062760.4164
Overseas EquitiesILLUMINA INC0.10582490.1691
Total 30.0032 47.9353
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.